|1.||Suzuki, Shunsuke: 1 article (05/2014)|
|2.||Kamo, Shuichi: 1 article (05/2014)|
|3.||Sato, Toshiro: 1 article (05/2014)|
|4.||Rao, A V: 1 article (01/2003)|
|5.||Gurfinkel, D M: 1 article (01/2003)|
|6.||Rowlands, J C: 1 article (12/2002)|
|7.||Badger, T M: 1 article (12/2002)|
|8.||Berhow, M A: 1 article (12/2002)|
|9.||Minowa, N: 1 article (03/2000)|
|10.||Nishiyama, S: 1 article (03/2000)|
03/10/2000 - "Protective effects of soyasapogenol A on liver injury mediated by immune response in a concanavalin A-induced hepatitis model."
03/10/2000 - "The present study was carried out to analyze the effects of soyasapogenol A on the liver injury mediated by the immune response in concanavalin A-induced hepatitis in mice. "
03/10/2000 - "Since the effect of soyasapogenol A on the elevated plasma TNF-alpha level was not appreciable compared to the preventive effect of soyasapogenol A on the elevated plasma alanine aminotransferase level, these results suggest that soyasapogenol A directly prevents apoptosis of hepatocytes, and secondly, inhibits the elevation of plasma TNF-alpha, which consequently resulted in the prevention of liver damage in the concanavalin A-induced hepatitis model."
|2.||Colonic Neoplasms (Colon Cancer)
01/01/2003 - "In this study, therefore, purified soyasaponins and soyasapogenins were tested for their ability to suppress the growth of HT-29 colon cancer cells, as determined by the WST-1 assay, over a concentration range of 0-50 ppm. Soyasaponin I and III, soyasapogenol B monoglucuronide, soyasapogenol B, soyasaponin A1, soyasaponin A2, and soyasapogenol A were evaluated. "
05/01/2014 - "The apical-to-basolateral absorption of soyasapogenol B in the Caco-2 human colon cancer monolayer cell model (apparent permeability coefficient [Papp], 5.5 × 10(-6) cm/sec) was higher than that of soyasapogenol A (Papp, 1.6 × 10(-6) cm/sec). "
|3.||Breast Neoplasms (Breast Cancer)
|4.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|6.||Alanine Transaminase (SGPT)
|7.||LY 165163 (PAPP)